SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The role of economic evaluation in the pricing and reimbursement of medicines
4 references·8 citing·40 second hop
The role of economic evaluation in the pricing and reimbursement of medicines (1997)The role of economic evaluation in the pr…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Quality of life and pharmacoeconomics in clinical trials (1996)Quality of life and pharmacoe…Quality of life and pharmacoeconomics in clinical trials (1996)Quality of life and pharmacoe…Pricing, Profits, and Technological Progress in the Pharmaceutical Industry (1993)Pricing, Profits, and Technol…Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with somatoform disorders (2013)Validity and responsiveness o…Structural changes in the German pharmaceutical market: Price setting mechanisms based on the early benefit evaluation (2013)Structural changes in the Ger…Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders (2010)Validity and responsiveness o…The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning (2007)The responsiveness of EQ-5D u…Economic evaluation in health: saving money or improving care? (2007)Economic evaluation in health…Impact of a generic substitution reform on patients’ and society's expenditure for pharmaceuticals (2006)Impact of a generic substitut…Reference-Based Pricing Schemes (2002)Reference-Based Pricing Schem…Current Trends in the Use of Pharmacoeconomics and Outcomes Research in Europe (1999)Current Trends in the Use of …Cost of innovation in the pharmaceutical industry (1991)Medical Care Costs: How Much Welfare Loss? (1992)Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs (1999)Generic entry, price competition, and market segmentation in the prescription drug market (2007)Economic and Political Weekly (2017)Payment Restrictions for Prescription Drugs under Medicaid (1987)A comparative analysis of generics markets in five European countries (2000)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance (2010)Forecasting drug utilization and expenditure in a metropolitan health region (2010)Review of the literature on reference pricing (2000)Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. (2002)Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors (2002)Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand (2003)Price control as a strategy for pharmaceutical cost containment—What has been achieved in Norway in the period 1994–2004? (2008)The Link Between Gross Profitability And Pharmaceutical R&D Spending (2001)Examining the link between price regulation and pharmaceutical R&D investment (2004)HEALTH TECHNOLOGY ASSESSMENT, VALUE-BASED DECISION MAKING, AND INNOVATION (2013)EuroQol - a new facility for the measurement of health-related quality of life (1990)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The PHQ-9 (2001)Multiple imputation to deal with missing EQ-5D-3L data: Should we impute individual domains or the actual index? (2014)Methods for the economic evaluation of health care programmes (1987)Economic Evaluation of Pharmaceuticals (1993)A Cost-Utility Analysis of Second-Line Chemotherapy in Metastatic Breast Cancer (1996)Economic Evaluations of Healthcare Programmes and Decision Making (2005)Pharmaceutical Pricing Policies in a Global Market (2008)Budget impact analysis in economic evaluation: a proposal for a clearer definition (2011)Construct validity in psychological tests. (1955)An inventory for measuring clinical anxiety: Psychometric properties. (1988)Cost-Effectiveness in Health and Medicine (1996)Impact of educational level on health-related quality of life (HRQL): results from Germany based on the EuroQol 5D (EQ-5D) (2012)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Evaluating patient-based outcome measures for use in clinical trials. (1998)The Health Utilities Index (HUI): concepts, measurement properties and applications. (2003)The PedsQL™* 4.0 as a Pediatric Population Health Measure: Feasibility, Reliability, and Validity (2003)Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items (2009)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1996Quality of life and pharmacoeconomics in clinical trials2,394 cited
  • 1996Quality of life and pharmacoeconomics in clinical trials1,857 cited
  • 1993Pricing, Profits, and Technological Progress in the Pharmaceutical Industry255 cited

Cited by

  • 2013Structural changes in the German pharmaceutical market: Price setting mechanisms based on the early benefit evaluation102 cited
  • 2010Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders95 cited
  • 2006Impact of a generic substitution reform on patients’ and society's expenditure for pharmaceuticals85 cited
  • 2013Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with somatoform disorders84 cited
  • 2002Reference-Based Pricing Schemes77 cited
  • 1999Current Trends in the Use of Pharmacoeconomics and Outcomes Research in Europe74 cited
  • 2007Economic evaluation in health: saving money or improving care?66 cited
  • 2007The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning65 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work